Login or sign up
For business

Anthos therapeutics

4.1· 9 reviews
Average ratingGreat
4.1/ 5

Based on 9 reviews

544%
422%
333%
20%
10%
Ask AI

Ask AI about Anthos therapeutics

Generated with AI from 9 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Tarun Tibrewala
Reviews 1

I recently had the opportunity to work with Anthos Therapeutics and I must say, they truly exceeded my expectations! Their team was incredibly knowledgeable and dedicated to providing the best possible solutions for our needs. The level of professionalism and attention to detail was outstanding. I would highly recommend Anthos Therapeutics to anyone looking for a reliable and efficient company to work with.

Andriya Kuzmin
Reviews 1

I recently utilized the services of this company and I was impressed with their high level of professionalism. They provided me with top-notch healthcare solutions without any hassle. I would highly recommend their services to anyone in need of reliable medical assistance.

Hector Macias
Reviews 1

I had a great experience working with this company. They provided exceptional service and delivered results beyond my expectations. Their expertise and attention to detail sets them apart from other providers in the industry. Highly recommended for anyone seeking a reliable partner in healthcare solutions.

Sarah Hamilton
Reviews 1

Anthos Therapeutics has been instrumental in helping us achieve our healthcare goals. Their expertise and professionalism are unparalleled. They consistently deliver outstanding results, and their attention to detail is commendable. Overall, a truly remarkable company to work with.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Anthos therapeutics

Accelerating the development of life-preserving therapies for patients at high-risk of cardiovascular diseases

Anthos Therapeutics: Accelerating the Development of Life-Preserving Therapies for Patients at High-Risk of Cardiovascular Diseases

Anthos Therapeutics is a biopharmaceutical company that is dedicated to accelerating the development of life-preserving therapies for patients who are at high-risk of cardiovascular diseases. The company was founded in 2018 by a team of experienced scientists and entrepreneurs who recognized the need for innovative solutions to address the growing burden of cardiovascular diseases.

Cardiovascular diseases are a leading cause of death worldwide, accounting for over 17 million deaths each year. These diseases include conditions such as heart attacks, strokes, and peripheral artery disease, which can have devastating consequences on patients' lives. Despite significant advances in medical research and treatment options, there remains an urgent need for new therapies that can prevent or treat these conditions effectively.

Anthos Therapeutics is focused on developing novel therapies that target specific pathways involved in cardiovascular disease progression. The company's approach involves identifying key molecular targets and developing small molecule drugs that can modulate these targets to prevent or reverse disease progression.

One area where Anthos Therapeutics has made significant progress is in the development of drugs targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), a protein involved in regulating cholesterol levels in the blood. Elevated levels of LDL cholesterol (often referred to as "bad" cholesterol) are a major risk factor for cardiovascular disease, and PCSK9 inhibitors have been shown to be highly effective at reducing LDL cholesterol levels.

Anthos Therapeutics has developed a proprietary platform technology called "ANT-001," which enables rapid identification and optimization of small molecule PCSK9 inhibitors with superior pharmacological properties compared to existing drugs on the market. The company's lead drug candidate, ANT-307, has demonstrated excellent efficacy and safety profiles in preclinical studies and is currently undergoing clinical trials.

In addition to its work on PCSK9 inhibitors, Anthos Therapeutics is also exploring other targets and pathways involved in cardiovascular disease progression. The company's research efforts are focused on identifying novel drug candidates that can address unmet medical needs in this area.

Anthos Therapeutics has a highly experienced team of scientists and executives with a proven track record of success in drug discovery and development. The company has established partnerships with leading academic institutions and pharmaceutical companies to leverage their expertise and resources in advancing its pipeline.

Overall, Anthos Therapeutics is well-positioned to make significant contributions to the field of cardiovascular medicine. With its innovative approach, cutting-edge technology platform, and strong team, the company is poised to develop life-preserving therapies that can improve the lives of millions of patients worldwide.

Address
55 cambridge parkway
Categories
Biotechnology